The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance

The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance

Abstract Background Radiotherapy (RT) is a highly effective multimodal nonsurgical treatment that is essential for patients with advanced colorectal cancer (CRC). Nevertheless, cell subpopulations displaying intrinsic radioresistance survive after RT. The reactivation of their proliferation and succ...

Full description

Bibliographic Details
Main Authors:	So-Yeon Park, Choong-Jae Lee, Jang-Hyun Choi, Jee-Heun Kim, Ji-Won Kim, Ji-Young Kim, Jeong-Seok Nam
Format:	Article
Language:	English
Published:	BMC 2019-09-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	Colorectal cancer (CRC) Radioresistance Janus kinase 2 (JAK2) Signal transducer and activator of transcription 3 (STAT3) Cyclin D2 (CCND2) Cancer stem cells (CSCs)
Online Access:	http://link.springer.com/article/10.1186/s13046-019-1405-7

Similar Items

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
by: Inés Roger, et al.
Published: (2021-05-01)

<i>Drosophila</i> Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
by: Sunny Trivedi, et al.
Published: (2018-12-01)

LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer
by: Lei Chang, et al.
Published: (2018-09-01)

Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages
by: Xin Zhang, et al.
Published: (2017-05-01)

CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo
by: Yifei Feng, et al.
Published: (2019-06-01)

MiR‐646 suppresses proliferation and metastasis of non‐small cell lung cancer by repressing FGF2 and CCND2
by: Jing Wang, et al.
Published: (2020-06-01)

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
by: Emira Bousoik, et al.
Published: (2018-07-01)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
by: Mario Cioce, et al.
Published: (2021-02-01)

Loss of SUMOylation on ATF3 Inhibits Proliferation of Prostate Cancer Cells by Modulating CCND1/2 Activity
by: Wei-Hsiung Yang, et al.
Published: (2013-04-01)

ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis
by: Valery Adorno-Cruz, et al.
Published: (2021-07-01)

Severe presentation and complex brain malformations in an individual carrying a CCND2 variant
by: Gerarda Cappuccio, et al.
Published: (2019-06-01)

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
by: Renata Mendes de Freitas, et al.
Published: (2015-10-01)

Aberrant methylation-mediated downregulation of lncRNA CCND2 AS1 promotes cell proliferation in cervical cancer
by: Chengcheng Zhao, et al.
Published: (2020-06-01)

LncRNA HOTAIR Promotes Cancer Stem-Like Cells Properties by Sponging miR-34a to Activate the JAK2/STAT3 Pathway in Pancreatic Ductal Adenocarcinoma
by: Deng S, et al.
Published: (2021-03-01)

Stomatin-like Protein 2 Promotes Tumor Cell Survival by Activating the JAK2-STAT3-PIM1 Pathway, Suggesting a Novel Therapy in CRC
by: Qiang Liu, et al.
Published: (2020-06-01)

Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
by: Florian Perner, et al.
Published: (2019-08-01)

NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo
by: Hua Y, et al.
Published: (2020-02-01)

Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications
by: Shuyu D. Li, et al.
Published: (2017-10-01)

Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression
by: Lucimari Bizari, et al.
Published: (2009-01-01)

Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
by: Jin-Zhang Cheng, et al.
Published: (2018-08-01)

Atractylenolide I Induces Apoptosis and Suppresses Glycolysis by Blocking the JAK2/STAT3 Signaling Pathway in Colorectal Cancer Cells
by: Yanxi Li, et al.
Published: (2020-03-01)

Phytochemicals Targeting JAK–STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models
by: Sun Young Moon, et al.
Published: (2021-05-01)

G Protein-Coupled Receptor GPR87 Promotes the Expansion of PDA Stem Cells through Activating JAK2/STAT3
by: Jianxin Jiang, et al.
Published: (2020-06-01)

Suppression of autophagy through JAK2/STAT3 contributes to the therapeutic action of rhynchophylline on asthma
by: Hui Li, et al.
Published: (2021-01-01)

Ceramide induces MMP-9 expression through JAK2/STAT3 pathway in airway epithelium
by: Lingling Xuan, et al.
Published: (2020-08-01)

The Influence of Compound Shougong Powder on JAK2-STAT3 Signaling Pathway in Mice with Lewis Lung Cancer
by: SHEN Di, et al.
Published: (2014-12-01)

Fructose 1,6-diphosphate alleviates myocardial ischemia reperfusion injury in rats through JAK2/STAT3 pathway
by: Ju-Fei Wang, et al.
Published: (2018-01-01)

Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer
by: Chia-Huei Lee, et al.
Published: (2019-01-01)

Identification of RNPC3 as a novel JAK2 fusion partner gene in B‐acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib
by: Xue Chen, et al.
Published: (2020-03-01)

Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer
by: Ya Cao, et al.
Published: (2020-06-01)

Circ-PITX1 Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1248/CCND2 Axis
by: Yue Q, et al.
Published: (2021-03-01)

Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer
by: Di Chen, et al.
Published: (2019-06-01)

DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression
by: Xiaomeng Li, et al.
Published: (2020-01-01)

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
by: Xue Hu, et al.
Published: (2021-04-01)

RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer
by: Annapurna Pranatharthi, et al.
Published: (2019-09-01)

CCND1 Splice Variant as A Novel Diagnostic and Predictive Biomarker for Thyroid Cancer
by: Sora Jeon, et al.
Published: (2018-11-01)

JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation
by: Han Ding, et al.
Published: (2021-12-01)

Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS
by: Jun-Rong Liang, et al.
Published: (2020-05-01)

Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
by: Xilan Yang, et al.
Published: (2020-03-01)

Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib
by: Lidong Liu, et al.
Published: (2020-09-01)